Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis

Summary

This study is a randomized, double-blind, placebo-controlled, multicenter clinical trial of about 70 subjects with moderate to severe plaque psoriasis.

Timeline

Start

2022-06-10

Primary completion

2023-08-30

Completion

2023-08-30

Drugs

Indications